Literature DB >> 25499232

Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.

Charnise Goodings1, Rati Tripathi1, Susan M Cleveland1, Natalina Elliott1, Yan Guo2, Yu Shyr2, Utpal P Davé3.   

Abstract

LIM domain only-2 (LMO2) overexpression in T cells induces leukemia but the molecular mechanism remains to be elucidated. In hematopoietic stem and progenitor cells, Lmo2 is part of a protein complex comprised of class II basic helix loop helix proteins, Tal1and Lyl1. The latter transcription factors heterodimerize with E2A proteins like E47 and Heb to bind E boxes. LMO2 and TAL1 or LYL1 cooperate to induce T-ALL in mouse models, and are concordantly expressed in human T-ALL. Furthermore, LMO2 cooperates with the loss of E2A suggesting that LMO2 functions by creating a deficiency of E2A. In this study, we tested this hypothesis in Lmo2-induced T-ALL cell lines. We transduced these lines with an E47/estrogen receptor fusion construct that could be forced to homodimerize with 4-hydroxytamoxifen. We discovered that forced homodimerization induced growth arrest in 2 of the 4 lines tested. The lines sensitive to E47 homodimerization accumulated in G1 and had reduced S phase entry. We analyzed the transcriptome of a resistant and a sensitive line to discern the E47 targets responsible for the cellular effects. Our results suggest that E47 has diverse effects in T-ALL but that functional deficiency of E47 is not a universal feature of Lmo2-induced T-ALL.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  E2A; LMO2; T-ALL; T-cell leukemia

Mesh:

Substances:

Year:  2014        PMID: 25499232      PMCID: PMC4277943          DOI: 10.1016/j.leukres.2014.11.016

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  50 in total

1.  mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor.

Authors:  S Huang; S J Brandt
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  LMO2 induces T-cell leukemia with epigenetic deregulation of CD4.

Authors:  Susan M Cleveland; Charnise Goodings; Rati M Tripathi; Natalina Elliott; Mary Ann Thompson; Yan Guo; Yu Shyr; Utpal P Davé
Journal:  Exp Hematol       Date:  2014-05-02       Impact factor: 3.084

3.  T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.

Authors:  G L Condorelli; F Facchiano; M Valtieri; E Proietti; L Vitelli; V Lulli; K Huebner; C Peschle; C M Croce
Journal:  Cancer Res       Date:  1996-11-15       Impact factor: 12.701

4.  Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia.

Authors:  Susan M Cleveland; Stephen Smith; Rati Tripathi; Elizabeth M Mathias; Charnise Goodings; Natalina Elliott; Dunfa Peng; Wael El-Rifai; Dajun Yi; Xi Chen; Liqi Li; Charles Mullighan; James R Downing; Paul Love; Utpal P Davé
Journal:  Stem Cells       Date:  2013-05       Impact factor: 6.277

5.  Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.

Authors:  Matthew P McCormack; Benjamin J Shields; Jacob T Jackson; Chayanica Nasa; Wei Shi; Nicholas J Slater; Cedric S Tremblay; Terence H Rabbitts; David J Curtis
Journal:  Blood       Date:  2013-08-07       Impact factor: 22.113

Review 6.  LIM-domain-only proteins in cancer.

Authors:  Jacqueline M Matthews; Krystal Lester; Soumya Joseph; David J Curtis
Journal:  Nat Rev Cancer       Date:  2013-01-10       Impact factor: 60.716

7.  Structural basis for LMO2-driven recruitment of the SCL:E47bHLH heterodimer to hematopoietic-specific transcriptional targets.

Authors:  Kamel El Omari; Sarah J Hoosdally; Kapil Tuladhar; Dimple Karia; Elisa Hall-Ponselé; Olga Platonova; Paresh Vyas; Roger Patient; Catherine Porcher; Erika J Mancini
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

8.  Causal analysis approaches in Ingenuity Pathway Analysis.

Authors:  Andreas Krämer; Jeff Green; Jack Pollard; Stuart Tugendreich
Journal:  Bioinformatics       Date:  2013-12-13       Impact factor: 6.937

9.  Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways.

Authors:  Chien-Hung Gow; Chun Guo; David Wang; Qiande Hu; Jinsong Zhang
Journal:  Nucleic Acids Res       Date:  2013-09-24       Impact factor: 16.971

10.  LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.

Authors:  Stephen Smith; Rati Tripathi; Charnise Goodings; Susan Cleveland; Elizabeth Mathias; J Andrew Hardaway; Natalina Elliott; Yajun Yi; Xi Chen; James Downing; Charles Mullighan; Deborah A Swing; Lino Tessarollo; Liqi Li; Paul Love; Nancy A Jenkins; Neal G Copeland; Mary Ann Thompson; Yang Du; Utpal P Davé
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more
  5 in total

1.  Hhex is Required at Multiple Stages of Adult Hematopoietic Stem and Progenitor Cell Differentiation.

Authors:  Charnise Goodings; Elizabeth Smith; Elizabeth Mathias; Natalina Elliott; Susan M Cleveland; Rati M Tripathi; Justin H Layer; Xi Chen; Yan Guo; Yu Shyr; Rizwan Hamid; Yang Du; Utpal P Davé
Journal:  Stem Cells       Date:  2015-05-27       Impact factor: 6.277

2.  Experimental glioma with high bHLH expression harbor increased replicative stress and are sensitive toward ATR inhibition.

Authors:  Marilin Sophia Koch; Stefan Czemmel; Felix Lennartz; Sarah Beyeler; Srinath Rajaraman; Justyna Magdalena Przystal; Parameswari Govindarajan; Denis Canjuga; Manfred Neumann; Patrizia Rizzu; Stefan Zwirner; Michael Stefan Hoetker; Lars Zender; Bianca Walter; Marcos Tatagiba; Olivier Raineteau; Peter Heutink; Sven Nahnsen; Ghazaleh Tabatabai
Journal:  Neurooncol Adv       Date:  2020-09-10

3.  LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.

Authors:  Justin H Layer; Catherine E Alford; W Hayes McDonald; Utpal P Davé
Journal:  Mol Cell Biol       Date:  2015-11-23       Impact factor: 4.272

Review 4.  ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?

Authors:  Bieke Soen; Niels Vandamme; Geert Berx; Jürg Schwaller; Pieter Van Vlierberghe; Steven Goossens
Journal:  Hemasphere       Date:  2018-05-11

5.  Genomic Profiling of T-Cell Neoplasms Reveals Frequent JAK1 and JAK3 Mutations With Clonal Evasion From Targeted Therapies.

Authors:  Allison Greenplate; Kai Wang; Rati M Tripathi; Norma Palma; Siraj M Ali; Phil J Stephens; Vincent A Miller; Yu Shyr; Yan Guo; Nishitha M Reddy; Lina Kozhaya; Derya Unutmaz; Xueyan Chen; Jonathan M Irish; Utpal P Davé
Journal:  JCO Precis Oncol       Date:  2018-02-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.